title: The efficacy of simvastatin is not influenced by CYP2D6 polymorphism.
authors.forename: Jürgen
authors.initials: J
authors.lastname: Geisel
authors.forename: Kari T
authors.initials: KT
authors.lastname: Kivistö
authors.forename: Ernst-Ulrich
authors.initials: EU
authors.lastname: Griese
authors.forename: Michel
authors.initials: M
authors.lastname: Eichelbaum
mesh_terms: D000483:Alleles; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000235:genetics*; D019821:Simvastatin / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000924:Anticholesteremic Agents; D019821:Simvastatin; D019389:Cytochrome P-450 CYP2D6